Citations

Clear

4510 citation(s) found for "Scott, C".

Overcoming the thermal limits of photon counting CT resolution using focal spot multiplexing: A feasibility study
Hsieh, Scott S.

Mayo Clinic

Medical Physics | January 25, 2025 | Volume: 52 | Issue: 4 | Pages: 2040-2051

10.1002/mp.17631 | PMID 39865312 Get It

AbstractBackgroundThe spatial resolution of new, photon counting detector (PCD) CT scanners is limited by the size of the focal spot. Smaller, brighter focal spots would melt the tungsten focal track of a conventional X‐ray source.PurposeTo propose focal spot multiplexing (FSM), an architecture to improve the power of small focal spots and thereby enable higher resolution clinical PCD CT. In FSM, the source rapidly alternates between multiple focal spot locations. The dwell time at each focal spot location is much shorter than the readout interval of the PCD, and each location is visited many times during the readout interval so that heat can be effectively distributed over a larger surface area. The PCD accumulates recorded events on the detector (prior to slip ring transmission) into multiple spatial bins, as a second dimension to conventional energy bins.MethodsWe estimated the maximum power permissible for a square, 0.2 mm focal spot assuming a maximum allowed surface temperature of 2900 K and a maximum transient temperature increase at the focal spot of 1400 K. This was performed using two separate thermal simulation codes: first, a commercial finite element method (FEM) was used to estimate bulk heating; second, a custom solver linearizing the heat equation was used to estimate track heating. FSM was simulated assuming that focal spot locations lay on parallel focal tracks, that instantaneous switching between tracks was possible, and that the space charge limit was never reached. We assumed a focal track velocity of 100 m/s and a 1 mm tungsten focal track layer with TZM alloy backing. The tube power was constant over a 4 s acquisition period.ResultsWithout FSM, the 0.2 mm focal spot could attain a maximum power output of 17 kW before reaching the thermal limit. FSM required a minimum switching frequency of 0.5 MHz to produce benefit. With two focal tracks and a switching frequency of 4 MHz, the power could be increased to 28 kW, and with eight focal tracks and a switching frequency of 16 MHz, the power could be increased to 98 kW. In all cases, the 1400 K transient increase thermal limit was reached before the 2900 K maximum surface temperature constraint. The relationship between maximum power, switching frequency, and number of focal tracks is discussed in relation to the underlying physics of heat transport.ConclusionsFocal spot multiplexing is an architecture that exploits the digital nature of photon counting to improve the power of high‐resolution CT X‐ray sources. With fast switching and several parallel focal tracks, it may be possible to halve the size of the focal spot while maintaining source power. This work motivates the development of new source technologies that can achieve fast electronic switching.
Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn’s Disease
Dillman, Jonathan R. , Tkach, Jean A. , Bruining, David H. , Lu, Aiming , Kugathasan, Subra , Knight‐Scott, Jack, Adler, Jeremy, Minar, Phillip , Bonkowski, Erin , Jurrell, Holden, Swanson, Scott D. , Fei, Lin , Qian, Lucia, Towbin, Alexander J. , Kocaoğlu, Murat , Anton, Christopher G. , Imbus, Rebecca, Denson, Lee A. , Kugathasan, Subra , Minar, Phillip , Dillman, Jonathan R , Fletcher, Joel G. , Alazraki, Adina , Stidham, Ryan W , Adler, Jeremy, Trapnell, Bruce C. , Lopez‐Nunez, Oscar , Collins, Margaret H. , Dudley, Jonathan A.

Mayo Clinic

Inflammatory Bowel Diseases | January 24, 2025 | Volume: 31 | Issue: 5 | Pages: 1380-1391

10.1093/ibd/izae319 | PMID 39853252 Get It

Abstract Background We previously identified circulating and MRI biomarkers associated with the surgical management of Crohn’s disease (CD). Here we tested associations between these biomarkers and ileal resection inflammation and collagen content. Methods Fifty CD patients undergoing ileal resection were prospectively enrolled at 4 centers. Circulating CD64, extracellular matrix protein 1 (ECM1), GM-CSF autoantibodies (GM-CSF Ab), and fecal calprotectin were measured by ELISA. Ileal 3-dimensional magnetization transfer ratio (3D MTR), modified Look-Locker inversion recovery (MOLLI) T1 relaxation, diffusion-weighted intravoxel incoherent motion (IVIM), and the simplified magnetic resonance index of activity (sMaRIA) were measured by MRI. Ileal resection specimen acute inflammation was graded, and collagen content was measured quantitatively using second harmonic imaging microscopy. Associations between biomarkers and ileal collagen content were tested. Results Median (interquartile range [IQR]) age was 19.5 (16-33) years. We observed an inverse relationship between ileal acute inflammation and collagen content (r = −0.39 [95% confidence interval {CI}: −0.61, −0.10], P = .008). Most patients (33 [66%]) received biologics, with no variation in collagen content with treatment exposures. In the univariate analysis, CD64, GM-CSF Ab, fecal calprotectin, and sMaRIA were positively associated with acute inflammation and negatively associated with collagen content (P < .1). The multivariable model for ileal collagen content (R2 = 0.31 [95% CI: 0.11, 0.52]) included log CD64 (β = −.27; P = .19), log ECM1 (β = .47; P = .06), log GM-CSF Ab (β = −.15; P = .01), IVIM f (β = .29, P = .10), and IVIM D* (β = 1.69, P = .13). Conclusions Clinically available and exploratory circulating and MRI biomarkers are associated with the degree of inflammation versus fibrosis in CD ileal resections. With further validation, these biomarkers may be used to guide medical and surgical decision-making for refractory CD.
Author response: Risk factors affecting polygenic score performance across diverse cohorts
Hui, D. , Dudek, Scott , Walunas, Theresa L. , Wei, Wei‐Qi, Tiwari, Hemant K., Khan, Atlas , Limdi, Nita A. , Feng, QiPing , Karlson, Elizabeth W. , Ritchie, Marylyn D. , Feng, Qiping , Walunas, Theresa L , Hui, Daniel, Kiryluk, Krzysztof , Kullo, Iftikhar J. , Peterson, Josh F. , Chung, Wendy K. , Davis, Brittney H. , Kottyan, Leah C. , Puckelwartz, Megan J. , Weng, Chunhua , Smith, Johanna L. , Jarvik, Gail P.

Mayo Clinic

No container title available | January 24, 2025 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.7554/elife.88149.3.sa2 Get It

Risk factors affecting polygenic score performance across diverse cohorts
Hui, Daniel , Dudek, Scott , Walunas, Theresa L. , Kullo, Iftikhar, Wei, Wei‐Qi, Tiwari, Hemant K., Limdi, Nita A. , Puckelwartz, Megan J, Karlson, Elizabeth W. , BioBank, Penn Medicine, Jarvik, Gail P., Ritchie, Marylyn D. , Walunas, Theresa L , Kiryluk, Krzysztof , Kullo, Iftikhar J. , Peterson, Josh F. , Chung, Wendy K. , Davis, Brittney H. , Khan, Atlas , Kottyan, Leah C. , Feng, QiPing , Puckelwartz, Megan J. , Weng, Chunhua , Smith, Johanna L. , BioBank, Penn Medicine, Jarvik, Gail P

Mayo Clinic

eLife | January 24, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.7554/elife.88149.3 Get It

Apart from ancestry, personal or environmental covariates may contribute to differences in polygenic score (PGS) performance. We analyzed the effects of covariate stratification and interaction on body mass index (BMI) PGS (PGS BMI ) across four cohorts of European (N = 491,111) and African (N = 21,612) ancestry. Stratifying on binary covariates and quintiles for continuous covariates, 18/62 covariates had significant and replicable R 2 differences among strata. Covariates with the largest differences included age, sex, blood lipids, physical activity, and alcohol consumption, with R 2 being nearly double between best- and worst-performing quintiles for certain covariates. Twenty-eight covariates had significant PGS BMI –covariate interaction effects, modifying PGS BMI effects by nearly 20% per standard deviation change. We observed overlap between covariates that had significant R 2 differences among strata and interaction effects – across all covariates, their main effects on BMI were correlated with their maximum R 2 differences and interaction effects (0.56 and 0.58, respectively), suggesting high-PGS BMI individuals have highest R 2 and increase in PGS effect. Using quantile regression, we show the effect of PGS BMI increases as BMI itself increases, and that these differences in effects are directly related to differences in R 2 when stratifying by different covariates. Given significant and replicable evidence for context-specific PGS BMI performance and effects, we investigated ways to increase model performance taking into account nonlinear effects. Machine learning models (neural networks) increased relative model R 2 (mean 23%) across datasets. Finally, creating PGS BMI directly from GxAge genome-wide association studies effects increased relative R 2 by 7.8%. These results demonstrate that certain covariates, especially those most associated with BMI, significantly affect both PGS BMI performance and effects across diverse cohorts and ancestries, and we provide avenues to improve model performance that consider these effects.
The PRO ‐ AGE Tool and Its Association With Post Discharge Outcomes in Older Adults Admitted From the Emergency Department
Cohen, Inessa , Morinaga, Christian Valle , Han, Ling, Araujo, Katy, Avelino‐Silva, Thiago Junqueira , Bianco, Luann, Capelli, Sandra, Cruz, Daniel S. , Fishman, Ivy L., Gipson, Katrina, Gray, Elizabeth , Hung, William W. , Kang, Raymond , Lockhart, Mechelle, Ohuabunwa, Ugochi , Ottilie‐Kovelman, Sierra, Platts‐Mills, Timothy F. , Sandoval, Jacqueline , Sifnugel, Natalia, Taylor, Zachary , Tomasino, Debra F. , Vaughan, Camille P. , Hwang, Ula , Carpenter, Christopher R , Cruz, Daniel S , Ohuabunwa, Ugochi , Sandoval, Jacqueline , Vaughan, Camille P , Aliberti, Márlon J R , Hwang, Ula , Avelino-Silva, Thiago Junqueira , Curiati, Pedro Kallas , Gandhi, Tanish , Brandt, Cynthia , Carpenter, Christopher R. , Dresden, Scott M. , Hastings, Susan N. , Meeker, Daniella , Taylor, Zachary

Mayo Clinic

Journal of the American Geriatrics Society | January 22, 2025 | Volume: 73 | Issue: 5 | Pages: 1419-1428

10.1111/jgs.19374 | PMID 39843218 Get It

ABSTRACT Background Existing risk scores assessing geriatric vulnerability in the emergency department (ED) have shown limited predictive power, especially in diverse populations. We investigated the relationship of a quick and easy‐to‐administer geriatric vulnerability scoring system with functional decline and mortality in older patients admitted to multiple hospitals through the ED in the United States (US) and Brazil (BR). Method Federated, international, multicenter observational study of hospitalized ED patients aged ≥ 65 from US and BR. The six criteria from the PRO‐AGE score (Physical impairment, Recent hospitalization, Older age [≥ 90], Acute mental alteration, Getting thinner, and Exhaustion; 0–8; higher scores = greater vulnerability) were assessed on admission. We used proportional hazards models to investigate the relationships between PRO‐AGE score groups and 90‐day mortality and functional decline, defined as new dependence in activities of daily living (ADL) and instrumental ADL (IADL), after adjusting for age, sex, race and ethnicity, education, Charlson comorbidity score, and study site. Death was considered a competing event for the functional decline outcome. Results A total of 1390 patients were included (US = 560; Brazil = 830). The 90‐day risk of death was higher for the upper compared with the lower (reference) PRO‐AGE group in both cohorts (US: HR = 11.76; 95% confidence interval [CI] = 2.56–54.04; BR: HR = 12.29; 95% CI = 3.54–42.59), whereas the risk of new 90‐day ADL disability was higher for upper (HR = 2.08; 95% CI = 1.21–3.56) and middle groups (HR = 2.10; 95% CI = 1.35–3.27) in the US but only the upper group in BR (HR = 1.70; 95% CI = 1.02–2.85). Conclusion A higher PRO‐AGE score was associated with mortality and functional decline in older ED patients admitted to hospitals in the US and BR, demonstrating its generalizability as a geriatric vulnerability risk score.
Syncope Induced by Dynamic Head and Shoulder Motion in the Setting of Left Subclavian Stenosis
Fearington, Forrest W. , Alajbegovic, Katarina , Brinjikji, Waleed , Holmes, Carmen R. , Khan, Muhib , Khan, Muhib , Scott, Jonathan M.

Mayo Clinic

The Neurologist | January 21, 2025 | Volume: 30 | Issue: 2 | Pages: 121-122

10.1097/nrl.0000000000000607 | PMID 39835436 Get It

Introduction: Dynamic vertebral artery insufficiency is a rare vascular phenomenon characterized by insufficient flow of the posterior cerebral circulation induced by dynamic motion of the head. Prior case reports have been limited to vertebral artery occlusion by cervical osteophytes or other structural impingements. Case Report: In this case report, we discuss the unusual case of a 61-year-old female with a history of vertigo, diplopia, nystagmus, and left subclavian stenosis admitted to the hospital for syncope elicited by a left head turn and left shoulder raise. Transcranial Doppler (TCD) ultrasound and angiography showed evidence of dynamic vertebrobasilar insufficiency elicited by a left-head turn. Percutaneous stenting of the left subclavian artery led to the resumption of normal vessel flow as assessed by TCD and the resolution of the patient’s symptoms. Conclusions: This case highlights an unusual cause of dynamic vertebrobasilar insufficiency induced by head turn and/or left shoulder raise due to subclavian stenosis, diagnosed by TCD and angiography, and successfully treated with subclavian artery stenting.
Evaluation and comparison of infusion reactions related to prophylactic medication timing for taxane administration
Noble, Jacob , Irvine, Clay, Tevaarwerk, AJ, Cole, Kristin , Gander, Kathleen, Soefje, Scott A. , Mara, Kristin C. , Irvine, Clayton , Tevaarwerk, Amy, Soefje, Scott A , Noble, Jacob M. , Mara, Kristin C , Shah, Vishal

Mayo Clinic

Journal of Oncology Pharmacy Practice | January 21, 2025 | Volume: 32 | Issue: 5 | Pages: 787-791

10.1177/10781552241313058 | PMID 39835368 Get It

Introduction Taxane medications, paclitaxel, and docetaxel, are chemotherapy agents that have a higher incidence of reported hypersensitivity and infusion reactions. To help classify these reactions, the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) is utilized. Prophylactic medications have been used to decrease the incidence and severity of these events. At our institution, medications that patients can receive prior to the initiation of a taxane infusion are a histamine 1 receptor antagonist (H1RA), histamine 2 receptor antagonist (H2RA), a steroid or a combination of these medications. The purpose of this retrospective review was to compare the rates and severity of infusion reactions based on the timing of prophylactic medication administration in the first and second doses of taxane infusions. Methods Patients who received paclitaxel or docetaxel from January 30 th , 2022, through January 30 th , 2023, were included in the analysis. To assist in the identification of a reaction, taxane administrations were flagged for review if a rescue medication was administered after the start of a paclitaxel or docetaxel infusion. The rates and severity of infusion reactions were analyzed based on the timing of prophylactic medication administration. A sub-group analysis comparing infusion reaction characteristics between taxanes given, was performed. Results Of the 1486 taxane infusions that were completed within the year, 249 infusion reactions were confirmed and graded utilizing the NCI CTCAE. When examining the first and second doses of a taxane (N = 536), we identified 222 infusions reactions. The odds of a patient having an infusion reaction, during the first and second doses, was found to be less likely for patients given a prophylactic medication 30 min prior to receiving a taxane compared to those who did not receive a pre-medication (p = 0.037). Conclusion This multisite retrospective study showed that administration of prophylactic medications 30 to 80 min prior to the first and second infusion of a taxane was the optimal timing to decrease the likelihood of patients having an infusion reaction. No difference in the severity of the reaction was seen. Most patients were able to complete the entire infusion, regardless of what rescue medications were used following the infusion reaction.
NCCN Guidelines® Insights: Lung Cancer Screening, Version 1.2025
Wood, Douglas E. , Kazerooni, Ella A. , Argento, Christine, Baines, Jonathan, Boer, Brian, Donington, Jessica , Eapen, Georgie A. , Ferguson, J. Scott , Hou, Lifang , Klippenstein, Donald, Kolansky, Ana S., Leung, Ann N. , Mazzone, Peter J. , Merritt, Robert E. , Norris, Kim, Onaitis, Mark W. , Pipavath, Sudhakar, Puri, Varun , Raz, Dan J. , Reddy, Chakravarthy, Reid, Mary E. , Sandler, Kim L. , Sears, Catherine R. , Tanoue, Lynn, Thacker, Amber L., Tong, Betty C. , Wei, Benjamin , McCullough, Beth, Ramakrishnan, Swathi , Hou, Lifang , Leung, Ann , Aberle, Denise R. , Brown, Lisa Marie , Kumar, Rohit , Leard, Lorriana E. , Sands, Jacob , Schabath, Matthew B. , Studts, Jamie L. , Thacker, Amber L., Travis, William D. , Westover, Kenneth D.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | January 15, 2025 | Volume: 23 | Issue: 1 | Pages: No page available

10.6004/jnccn.2025.0002 | PMID 39819601 Get It

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Lung Cancer Screening provide criteria for selecting individuals for screening and offer recommendations for evaluating and managing lung nodules detected during initial and subsequent annual screening. These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Lung Cancer Screening.
Abstract 273: Evaluating Clinical Outcomes and Cost‐Effectiveness of Robotic Carotid Artery Stenting: A Multi‐Center, Propensity Score Matched Study
Patel, Sheel , Scott, Kyle, Abbas, Richat, Fuleihan, Antony A. , Sivaganesan, Ahilan, Tjoumakaris, Stavropoula , Gooch, M, Rossenwasser, Robert H., Srinivasan, Visish M. , Burkhardt, Jan‐Karl , Jabbour, Pascal , Roy, J., Musmar, Basel , Sarikonda, Advith , Scott, K., Abbas, R., Jabbour, Pascal

Mayo Clinic

Stroke: Vascular and Interventional Neurology | January 15, 2025 | Volume: 4 | Issue: S1 | Pages: No page available

10.1161/svin.04.suppl_1.273 Get It

Objective Preclinical studies suggest that robotic carotid artery stenting (CAS) could be superior to manual CAS. However, very limited comparative data exists comparing robotic and manual CAS patients. In addition, no data exists comparing the costs of manual and robotic CAS. Methods All robotic CAS cases at 2 academic neurosurgery centers were retrospectively reviewed and 1:1 propensity matched with manual CAS cases. Personnel costs, supply costs, and total procedure costs were collected in collaboration with hospital administration using time‐driven activity‐based cost‐analysis (TDABC). Results 24 robotic CAS cases were performed between 2019 and 2023. Co‐morbidities and baseline procedural characteristics were well‐matched between robotic and manual cases. Unplanned manual conversion was observed in only one robotic case (4.2%). Robotic CAS complications and outcomes were comparable to manual. Robotic CAS was associated with a significantly increased fluoroscopy time (29.0 vs. 19.2 min.; p<0.001). Robotic procedure time (88.9±18.2 min.) was significantly (p=0.003) higher than manual (68.72±22.4 min.). Health professional costs ($1,589.71±176.92, $1,375.99±233.39, p<0.005), supply cost ($3,918.25±421.20, $2,152.74±1,030.26, p<0.001) and total procedure costs ($5,306.11±608.95, $3,437.56±1,165.67, p<0.001) were greater for robotic CAS. Conclusions With a low rate of technical failure and post‐operative complications, we show robotic carotid artery stenting is safe and feasible in the first multi‐center and largest sample to date. In addition, robotic CAS achieves comparable clinical outcomes. Robotic CAS was associated with increased fluoroscopy time, but fluoroscopy time decreased as operators gained familiarity with the CorPath GRX. Robotic CAS was associated with a greater procedural cost, which was driven by greater personnel and supply costs. Our findings highlight the need for further studies to optimize robotic CAS and reduce its associated costs.